Global Robotic Angiography Systems Market To Growth with a CAGR of ~6% During 2031

Research Nester published a report titled “Robotic Angiography Systems Market: Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global robotic angiography systems market in terms of market segmentation by technology, application, indication, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global robotic angiography systems market is estimated to garner a moderate revenue by the end of 2031 by growing at a CAGR of ~6% over the forecast period, i.e., 2022 – 2031. Further, the market generated a modest revenue in the year 2021.The market is segmented and analyzed for demand and supply by end-user into hospitals, specialty clinics, diagnostic & imaging centers, and academic & research institutes, out of which, the hospitals segment is anticipated to garner the largest revenue by the end of 2031. One of the major factors anticipated to drive the growth of the segment is the increasing number of patient visits in hospitals, followed by the rising availability of hospitals around the globe.

The global robotic angiography systems market isexpected to grow on account of the increasing integration of automation in the healthcare industry, along with the surge in trends of internet of things (IoT) in healthcare, also known as internet of medical things (IoMT). Besides this, the growing advancements in the development of novel robotic imaging solutions along with the availability of several government initiatives to promote R&D in the field of healthcare are also poised to generate numerous opportunities for the growth of the market in the coming years.

The global robotic angiography systems market is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East & Africa, out of which, the market in North America is projected to hold the largest market share by the end of 2031. Surge in the number of hospitals and diagnostic & imaging centers, followed by the presence of a strong healthcare network, and the rising awareness amongst the healthcare service providers for advanced robot-assisted minimally invasive diagnostic imaging devices are some of the major factors anticipated to drive the growth of the market in the region.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Increasing Adoption of Advanced Medical Robotics by Healthcare Service Providers to Promote Market Growth

The current health expenditure as a share of GDP worldwide, according to the statistics by the World Bank, touched 9.84% in the year 2019, up from 8.63% in the year 2000.

Backed by the rising expenditure on healthcare, and the growing incidences of different types of diseases, there is a rising need amongst the healthcare service providers to adopt advanced diagnostic devices that are assisted by robots. These advanced medical robots aid in the early diagnosis of diseases which in turn, is expected to drive the demand for the product. Such a factor is therefore expected to boost the growth of the global robotic angiography systems market during the forecast period.

However, the concern for exposure to radiation, along with the high probability of injury caused due to catheterized artery, are some of the major factors expected to operate as key restraint to the growth of global robotic angiography systems market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global robotic angiography systems market which includes company profiling of General Electric (GE Healthcare), KUKA AG, Koninklijke Philips N.V., Siemens Healthcare GmbH, Corindus, Inc., Shimadzu Corporation, Boston Scientific Corporation, Abbott, Canon Medical Systems Corporation, Medtronic Plc, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global robotic angiography systems market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.      

Request Report Sample@ https://www.researchnester.com/sample-request-4163

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: [email protected]

U.S. Phone: +1 646 586 9123 

U.K. Phone: +44 203 608 5919